about
Immune modulation during latent herpesvirus infectionEpstein-Barr virus infection is not a characteristic feature of multiple sclerosis brainInfection as an Environmental Trigger of Multiple Sclerosis Disease ExacerbationInfectious MononucleosisEpstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationSystematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosisThe role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differencesReal-time PCR in clinical microbiology: applications for routine laboratory testing.Advances in Pediatric NeurovirologyEpstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patientsElevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosisEnvironmental risk factors in multiple sclerosis.Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.Tracing environmental markers of autoimmunity: introducing the infectome.Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis.Primary infection with the Epstein-Barr virus and risk of multiple sclerosisInduction of encephalitis in rhesus monkeys infused with lymphocryptovirus-infected B-cells presenting MOG(34-56) peptide.Common viruses associated with lower pediatric multiple sclerosis risk.Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.The initiation and prevention of multiple sclerosis.Epstein-barr virus: environmental trigger of multiple sclerosis?Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity.Treatment of children and adolescents with multiple sclerosis.Dysregulated Epstein-Barr virus infection in the multiple sclerosis brainDoes the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?Does the season or month of birth influence disease progression in multiple sclerosis?Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.Epstein-Barr virus in oral shedding of children with multiple sclerosis.Pediatric multiple sclerosis: current concepts and consensus definitions.99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence.Risk factors in the development of multiple sclerosis.Therapies for multiple sclerosis: considerations in the pediatric patient.Common infectious agents in multiple sclerosis: a case-control study in children.Environmental triggers of multiple sclerosis.Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells.Pathogenesis of pediatric multiple sclerosis.Acute disseminated encephalomyelitis progressing to multiple sclerosis: are infectious triggers involved?Long-term prognosis of pediatric patients with relapsing acute disseminated encephalomyelitis.
P2860
Q24624044-2D935965-E5CD-468D-ACDE-996B940390D5Q24642187-57605A0A-EAD8-47A6-9391-BAF11B5B4E09Q26779416-D6C0F1B0-63DB-4897-B7BE-D824F55655AAQ26783692-5D1D7AA5-CA6E-4205-85FE-06E082F1CE0AQ26830464-4A590D28-17C3-4B8E-AB93-38562FF9CAB6Q26852295-0971C445-5BF5-42A2-A25E-021E4B073F53Q26866256-3CBCC469-B050-4572-8CA4-A51BF5BB331BQ27472851-85BBECC8-09E9-4AD0-940B-17409FEA0B58Q27491302-B4B448DD-8FCC-466D-81BE-95DBDF1E7473Q31104121-E858E969-24F5-45CB-BA50-8403C857AC25Q33764503-696FC0AB-3B26-41E3-8AED-DDDD62F76167Q34100847-B6C81C71-24FE-40D9-AEA0-6EC8611B0DC8Q34280356-B43439FA-EA6A-4E9C-8F65-83AFE9076473Q34671373-E7659836-C56A-4E01-ABB2-E31E9B46D3ABQ34902029-461CB121-A0B1-45D4-9C5F-3650E428DA1AQ34952674-6CFF1FD8-CADF-4DC3-A0F5-03F92E2474E3Q34971488-803201F6-98DB-41D1-BA81-507A163F43BDQ35030410-DD5FAB4E-2472-4E63-AC7E-A6A47970C917Q35228937-5B97B394-32B4-4C02-BDEE-9047EA126D70Q35231431-2E86DF3E-9EE2-4425-BCDB-9AB64CAE1E12Q35741861-2A0BF771-1748-48ED-B29D-A6FF8B74B9C4Q35914342-2267C3C4-7C07-4CF8-A4EB-AE897BD48A55Q36004599-2B64CD95-4919-486F-BEA0-ED56C42EFA91Q36153390-E4373E1C-D711-4F35-8C14-6721A356B28FQ36229219-1AB85247-1003-4C8A-B6D6-E5EB344BBDEBQ36314027-538C4B16-425E-40F2-9C4F-AE6C30A14185Q36433472-7AAE3E25-9B03-42AA-9C2E-A74644F8778FQ36645538-20CF927A-B6FB-4D57-A78C-436F78117E3EQ37146126-2C694FDC-D4AF-4918-85E6-E7E7369DF189Q37251625-8F044CCA-FC9D-473E-B5EA-F98756ECADE5Q37330502-03F80B42-C3A5-4EFC-A9B5-219B09B824E3Q37736591-BDA768DD-3CBD-48A6-A66C-B86D4AC5B528Q37754653-C3F36BF2-024A-4D01-9603-D7BD5129359EQ37827690-87ED5FB9-CAB6-47D8-952F-D2656ED962DEQ37858893-414E21FC-5628-40C3-9E4B-5D37D5D92629Q37864387-5FD55BF3-79D1-4653-A5AA-CC5E733943C9Q37998396-85367685-4D37-46D5-9381-6F5F1E05A182Q38041081-FF7201BE-F97A-4EFC-80D8-EA4682725E05Q38199387-03E1E492-8170-4B75-9B1B-5D7F44955FEFQ38470871-4A86D667-BC72-4ECC-BF30-434A2B308401
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Epstein-Barr virus in pediatric multiple sclerosis.
@en
type
label
Epstein-Barr virus in pediatric multiple sclerosis.
@en
prefLabel
Epstein-Barr virus in pediatric multiple sclerosis.
@en
P2093
P356
P1476
Epstein-Barr virus in pediatric multiple sclerosis.
@en
P2093
Brenda Banwell
Derek Stephens
Julia Kennedy
Raymond Tellier
Suad Alotaibi
P304
P356
10.1001/JAMA.291.15.1875
P407
P577
2004-04-01T00:00:00Z